Multi-Day Therapeutic Fasting: Benefits, Risks and Medical Supervision

If the idea of a “reset” sounds appealing, start with the least dramatic answer: a multi-day fast has not been shown to extend human life. Some protocols change weight, glucose, blood pressure or liver fat over the short term. They can also cause dizziness, low blood pressure, hypoglycaemia, loss of fat-free mass and problems when food is reintroduced.

That does not make fasting useless or dangerous for everyone. It makes it an intervention that needs a precise question: what are we trying to change, what evidence applies to someone like you, and what risk are we accepting?

Evidence review: 29 August 2026. We reviewed indexed literature, clinical consensus documents and visible Spanish and English results to separate this guide from general articles about intermittent fasting and autophagy. Search results contain many benefit lists and few decision frameworks. This page therefore focuses only on multi-day fasting, medication, fat-free mass, contraindications and refeeding. It is educational and does not replace medical assessment.

What we mean by therapeutic fasting here

In this guide, therapeutic fasting means a planned period of two or more days with little or no energy intake, a defined goal and a plan for returning to food. Longo and colleagues distinguish intermittent fasting lasting 12-48 hours from periodic fasting lasting 2-7 days. That classification is useful, but it does not turn every multi-day protocol into a proven treatment.

A 12/12 or 16/8 window is a different conversation. If you want an everyday eating pattern, see our guide to intermittent fasting and autophagy. Here we address the more delicate decision: spending several days on minimal intake without mistaking ketosis for rejuvenation.

This is not a detox claim either. Your liver and kidneys do not need food deprivation to remember their jobs. Fasting changes metabolism, but no clinical test shows that it removes unspecified toxins or resets the body.

The short answer to six important questions

Question	Honest answer	What remains unknown
Does it extend life?	This has not been shown in humans.	Long trials measuring disease, mortality and quality of life, not biomarkers alone.
Does it improve metabolism?	Some protocols improve short-term markers in selected groups.	How long effects last and whether they outperform sustainable nutrition with similar energy loss.
Does it activate autophagy?	It changes pathways related to AMPK, mTOR and autophagy.	There is no validated human autophagy clock or guaranteed clinical benefit from reaching ketosis.
Does it reduce fat?	Fat mass and waist can fall.	Weight loss also includes water and fat-free mass.
Is it safe?	Selected people may tolerate it inside clinical settings.	Safety at home, with medication or with disease, is much less certain.
Is it better than a conventional diet?	Not in general. For intermittent fasting, Cochrane found little or no meaningful difference from regular dietary advice.	Which specific people gain enough extra benefit to justify the complexity.

What human evidence has found

The evidence does not fit into “works” or “does not work”. Protocols differ, samples are often small and outcomes are usually measured over weeks or months.

• Intermittent fasting: the 2026 Cochrane review included 22 studies and 1,995 adults with overweight or obesity. Compared with regular dietary advice, it found little or no difference in weight loss or quality of life. Evidence about adverse events was very uncertain. The review covers several patterns, so it challenges claims of overall superiority rather than settling the safety of a specific multi-day retreat.
• Buchinger-style periodic fasting: an observational study followed 1,422 people through 4-21-day fasts providing 200-250 kcal per day in a specialist clinic. Weight, waist, blood pressure and selected metabolic markers fell; adverse effects were reported in fewer than 1%. There was no control group, participants were selected and care was structured. It does not show that home fasting is equally safe or prevents disease.
• Fasting-mimicking diet: a 2017 trial assigned 100 generally healthy adults to their usual diet or five-day monthly cycles for three months. Weight, trunk fat, blood pressure and IGF-1 fell, with no serious adverse effects reported; 71 participants completed three cycles across both phases. The result is interesting, but short and small.
• Biological age: a 2024 analysis of two trials associated three fasting-mimicking cycles with lower insulin resistance, lower liver fat and a 2.5-year reduction in estimated biological age. This was a secondary, exploratory analysis of a marker, not proof of living 2.5 years longer. L-Nutra supplied the diet; USC holds licensed intellectual property and two authors disclosed equity in the company.

The useful conclusion is modest: short-term intermediate markers may improve in some people, but we do not know whether this means fewer heart attacks, cancers, dementia cases or deaths. A clinic promising proven rejuvenation is moving ahead of the evidence.

The scale goes down, but it does not tell the whole story

This is one of the details most often lost online. A 2026 systematic review and meta-analysis brought together 49 prolonged-fasting studies. It found reductions in weight, BMI, fat mass and waist circumference, but also in fat-free mass and total body water.

Fat-free mass is not identical to muscle: it includes water, glycogen, organs and other tissues. Fluid shifts explain part of the change during fasting. Even so, the finding prevents us from celebrating every lost kilogram as visceral fat. For an older, lean, frail or weak person, that trade may work against the goal of healthy ageing.

A serious protocol is therefore not judged by weight alone. It considers the prior weight trajectory, function, strength, body composition when useful and recovery of food intake afterwards. The goal is not to endure the longest fast; it is to avoid weakening the reserve that keeps you independent.

Who should not start a multi-day fast on their own

This table cannot replace a medical history, but it highlights situations in which risk changes meaningfully.

Situation	Why it matters	Prudent decision
Diabetes or glucose-lowering medication	Hypoglycaemia or other metabolic instability can occur if intake changes without treatment adjustment.	Do not start or alter medication without the prescriber.
Antihypertensives, diuretics or other medication sensitive to hydration and food	Blood pressure, circulating volume and electrolytes may change.	Review medication and stopping rules first.
Low weight, frailty, sarcopenia or recent weight loss	There is less reserve and a higher potential cost from losing fat-free mass.	Prioritise nutritional and functional recovery.
Current or previous eating disorder	Restriction may reactivate preoccupation, compensation or relapse.	Avoid fasting unless a specialist team gives a clear indication.
Pregnancy, breastfeeding or childhood	Energy and nutrient requirements are different.	Do not use prolonged fasting for longevity or weight control.
Kidney or liver disease, gout, arrhythmia, fainting or complex cardiovascular history	Metabolic, volume and electrolyte shifts may destabilise disease.	Only consider it with the team responsible for the condition.
Active cancer, recent surgery or acute illness	Nutritional risk and treatment needs take priority.	Do not improvise or use fasting instead of treatment.

Fainting, confusion, chest pain, persistent palpitations, repeated vomiting, severe weakness or inability to keep fluids down are not signs that “detox is working”. Stop the protocol and seek help.

Medication is reviewed before a fast, not during a crisis

Fasting does not suspend pharmacology. Some medicines depend on food; others may amplify a glucose or blood-pressure drop when intake disappears. The answer is not to stop tablets on your own.

Before the first day, the clinician who knows the treatment should decide what continues, what changes, what is monitored and what symptoms mean stop. A ketone app or smartwatch cannot replace that decision. If a programme does not include a real medication review, “supervised” is doing too much work.

Refeeding: returning to food is part of the protocol

After several days, breaking a fast with a huge meal may feel awful. In vulnerable people, the problem can be more serious: reintroducing energy changes insulin, phosphate, potassium, magnesium and thiamine requirements. Refeeding syndrome is uncommon, but it can affect the heart, nervous system and other organs.

The 2020 ASPEN consensus defines the syndrome through falls in phosphate, potassium or magnesium, with or without organ dysfunction or thiamine deficiency, during the five days after calories return. The 2025 AuSPEN consensus notes that the full syndrome is uncommon, but risk still needs assessment and vulnerable people need thiamine, vitamins and regular electrolyte monitoring.

The practical lesson is not to copy a universal online menu. It is to match the return to food to fasting duration and nutritional status. Someone at risk needs a clinical plan, possible supplementation and electrolyte monitoring. The celebration dinner can wait.

What real supervision should include

1. Before: a concrete objective, weight history, relationship with food, conditions, medication and nutritional assessment. Tests should be chosen because risk requires them, not to create an impressive panel.
2. During: clinical contact, symptoms, hydration, blood pressure and the measures relevant to that person's risk. There must be clear criteria for shortening or stopping the fast.
3. After: planned refeeding, a tolerance check and recovery of normal food, activity and training.
4. Follow-up: verify whether the original target changed. A temporary drop on the scale is not enough to call the intervention successful.

At Progevita, we view fasting as one possible tool within personalised preventive medicine, not as a willpower test. A good team should also be willing to tell you not to fast and offer a simpler option: regular meal timing, better nutrition, rebuilding strength, improving sleep or treating the problem that is actually driving risk.

How to decide whether it is worth considering

• If the goal is simply to “activate autophagy”, the benefit is too abstract to justify an aggressive protocol.
• If the goal is rapid weight loss, remember that fasting has not shown general superiority and that some change may be water and fat-free mass.
• If medication, disease, low weight or a fragile relationship with food is present, professional assessment comes before a start date.
• If a less intense option can reach the same goal, it usually deserves the first trial.

The adult question is not “how many days can I last?”. It is “what decision improves my health six months from now without harming me this week?”.

Frequently asked questions

What is therapeutic fasting?

Here it means a planned period of two or more days with little or no energy intake and a defined clinical goal. It is different from eating dinner early or following a 16/8 window.

Does prolonged fasting activate autophagy?

It changes autophagy-related pathways, but there is no universal hour or home test that measures “how much autophagy” is occurring in a human tissue. The mechanism does not prove rejuvenation.

Does therapeutic fasting extend lifespan?

This has not been shown in humans. Available studies focus on animals, mechanisms and short-term biomarkers, not living longer.

Are intermittent fasting and therapeutic fasting the same?

No. Intermittent fasting usually arranges windows within a day or week. The fasting discussed here lasts several days and requires review of medication, nutrition and refeeding.

Should medication be changed during a fast?

Sometimes adjustment may be needed, but never without the prescriber. Treatment should be reviewed before the fast, with written monitoring and stopping rules.

Who should not do prolonged fasting?

Pregnant or breastfeeding people, minors and anyone with low weight, frailty, recent weight loss, current or previous eating disorder, diabetes, kidney or liver disease, gout, active cancer, recent surgery or sensitive medication should avoid it or discuss it with their team.

Can fasting cause muscle loss?

Fat-free mass can fall. That measure includes muscle, but also water and other tissues, so weight alone cannot tell you what was lost.

How do you break a fast safely?

It depends on duration and nutritional risk. After several days, a large meal is not a plan. People with prolonged low intake, weight loss or low electrolytes need clinical guidance.

Conclusion

Therapeutic fasting can change biomarkers in some people, but it has not been shown to extend life and it is not a fast-forward version of preventive medicine. Its value depends on the goal, selection, supervision and what happens afterwards.

If you are considering a multi-day fast, start with medication, nutritional status, muscle reserve and less intense alternatives. Talk to the Progevita team if you want to assess whether it fits your situation. The best decision may be a carefully designed protocol or deciding that you do not need one.

References

1. Longo VD et al. Intermittent and periodic fasting, longevity and disease. Nature Aging. 2021. PMID 35310455.
2. Garegnani LI et al. Intermittent fasting for adults with overweight or obesity. Cochrane Database of Systematic Reviews. 2026. PMID 41692034.
3. Ulupınar S et al. Duration-Dependent Changes in Body Composition During Prolonged Fasting: A Systematic Review and Meta-Analysis. Nutrition Reviews. 2026. PMID 42440276.
4. Wilhelmi de Toledo F et al. Safety, health improvement and well-being during a 4 to 21-day fasting period in 1,422 subjects. PLOS ONE. 2019. PMID 30601864.
5. Wei M et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Science Translational Medicine. 2017. PMID 28202779.
6. Brandhorst S et al. Fasting-mimicking diet causes hepatic and blood marker changes indicating reduced biological age and disease risk. Nature Communications. 2024. PMID 38378685.
7. Wilhelmi de Toledo F et al. Fasting therapy: an expert panel update of the 2002 consensus guidelines. Forschende Komplementärmedizin. 2013. PMID 24434758.
8. da Silva JSV et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutrition in Clinical Practice. 2020. PMID 32115791.
9. Matthews-Rensch K et al. The Australasian Society of Parenteral and Enteral Nutrition: Consensus statements on refeeding syndrome. Nutrition & Dietetics. 2025. PMID 40090863.